Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01695031 · ClinicalTrials.gov registry record · NA

Feasibility of an ED Initiated Online Asthma Management Program for Urban Teens

A NA study, sponsored by Henry Ford Health System.

Completed
Registry status
NA
Development phase
126
Enrollment target

NCT01695031 is a NA study that has completed, run by Henry Ford Health System. The registered enrollment target is 126 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01695031, a NA study, has completed, sponsored by Henry Ford Health System.

COMPLETED
Registry status
NA
Development phase
126 participants
Enrollment target

Study Summary

The objective of this study is to determine the feasibility of conducting a randomized controlled trial to evaluate the effectiveness of an online, Emergency Department-initiated asthma management intervention designed to reduce asthma-related morbidity among urban teenagers aged 13-19 years with uncontrolled asthma. The study will examine issues around recruitment, participant compliance with the study protocol, Internet access, and attrition. Investigators will first develop a protocol for recruiting 13-19 year old patients with acute asthma into an ED-initiated pilot trial of an online asthma management program, describing recruitment and refusal rates. Investigators will measure participant compliance with the pilot study protocol including 4 online sessions and a 6 month survey. Investigators will also measure compliance of the participants parents at baseline and a six month follow up. Investigators will then use pilot study results to describe the intervention effect on selected outcomes including ED visits, asthma control as measured by Asthma Control Questionnaire, functional limitations, quality of life, and behavior change.

Interventions

  • BEHAVIORAL Tailored asthma management program
  • BEHAVIORAL Generic web-based education

Trial Details

FieldValue
Enrollment Target 126 participants
Start Date 2012-10
Est. Completion 2015-03
Phase NA

Sponsor

Henry Ford Health System

234 total trials

What the Registry Record Tells You About NCT01695031

The ClinicalTrials.gov registry entry for NCT01695031 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Tailored asthma management program is the first listed.

NCT01695031 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01695031 about?

NCT01695031 is a clinical study titled "Feasibility of an ED Initiated Online Asthma Management Program for Urban Teens". The objective of this study is to determine the feasibility of conducting a randomized controlled trial to evaluate the effectiveness of an online, Emergency Department-initiated asthma management intervention designed to reduce asthma-related morbidity among urban teenagers aged 13-19 years with un...

What is the current status of trial NCT01695031?

This trial is currently completed. It is a NA study. The enrollment target is 126 participants. The study started on 2012-10. Estimated completion is 2015-03.

What interventions are being tested in trial NCT01695031?

The interventions under investigation include: Tailored asthma management program (BEHAVIORAL), Generic web-based education (BEHAVIORAL).

Who is sponsoring clinical trial NCT01695031?

This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.